Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Systole
A qualitative analysis of patients' experience with hospitalist service handovers.
A phase II study of a human anti-PDGFRa monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.
Biophysical model for gamma rhythms in the olfactory bulb via subthreshold oscillations.
MET receptor in oncology: From biomarker to therapeutic target.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET receptor in oncology: From biomarker to therapeutic target.
MET receptor in oncology: From biomarker to therapeutic target. Adv Cancer Res. 2020; 147:259-301.
View in:
PubMed
subject areas
Animals
Biomarkers, Tumor
Humans
Molecular Targeted Therapy
Neoplasms
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Randomized Controlled Trials as Topic
Signal Transduction
authors with profiles
Ravi Salgia